{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T20:08:15Z","timestamp":1793650095155,"version":"4.5.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-15089-3","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T13:02:50Z","timestamp":1756818170000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Deep learning model for screening causes of activated partial thromboplastin time prolongation using clot waveform analysis at multiple wavelengths"],"prefix":"10.1038","volume":"15","author":[{"given":"Masato","family":"Matsuda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiki","family":"Shimomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Tabuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kurono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Nishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuo","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Hoshiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikio","family":"Kamioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Moriyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,2]]},"reference":[{"key":"15089_CR1","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1055\/s-0028-1104539","volume":"34","author":"G Lippi","year":"2008","unstructured":"Lippi, G. & Favaloro, E. J. Activated partial thromboplastin time: new tricks for an old dogma. Semin Thromb. Hemost. 34, 604\u2013611 (2008).","journal-title":"Semin Thromb. Hemost."},{"key":"15089_CR2","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1055\/s-0038-1677018","volume":"45","author":"EJ Favaloro","year":"2019","unstructured":"Favaloro, E. J., Kershaw, G., Mohammed, S. & Lippi, G. How to optimize activated partial thromboplastin time (APTT) testing: solutions to Establishing and verifying normal reference intervals and assessing APTT reagents for sensitivity to heparin, lupus anticoagulant, and clotting factors. Semin Thromb. Hemost. 45, 22\u201335 (2019).","journal-title":"Semin Thromb. Hemost."},{"key":"15089_CR3","doi-asserted-by":"publisher","first-page":"420","DOI":"10.3390\/diagnostics13030420","volume":"13","author":"E Zanon","year":"2023","unstructured":"Zanon, E. Acquired hemophilia A: an update on the etiopathogenesis, diagnosis, and treatment. Diagnostics (Basel). 13, 420 (2023).","journal-title":"Diagnostics (Basel)"},{"key":"15089_CR4","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1002\/rth2.12252","volume":"3","author":"ACN Barbosa","year":"2019","unstructured":"Barbosa, A. C. N. et al. Prolonged APTT of unknown etiology: A systematic evaluation of causes and laboratory resource use in an outpatient hemostasis academic unit. Res. Pract. Thromb. Haemost. 3, 749\u2013757 (2019).","journal-title":"Res. Pract. Thromb. Haemost"},{"key":"15089_CR5","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1111\/ejh.13394","volume":"104","author":"KL Rasmussen","year":"2020","unstructured":"Rasmussen, K. L., Philips, M., Tripodi, A. & Goetze, J. P. Unexpected, isolated activated partial thromboplastin time prolongation: A practical mini-review. Eur. J. Haematol. 104, 519\u2013525 (2020).","journal-title":"Eur. J. Haematol."},{"key":"15089_CR6","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/ajh.25669","volume":"95","author":"EJ Favaloro","year":"2020","unstructured":"Favaloro, E. J. Coagulation mixing studies: utility, algorithmic strategies and limitations for lupus anticoagulant testing or follow up of abnormal coagulation tests. Am. J. Hematol. 95, 117\u2013128 (2020).","journal-title":"Am. J. Hematol."},{"key":"15089_CR7","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1055\/s-0033-1336832","volume":"39","author":"G Kershaw","year":"2013","unstructured":"Kershaw, G. & Orellana, D. Mixing tests: diagnostic aides in the investigation of prolonged prothrombin times and activated partial thromboplastin times. Semin Thromb. Hemost. 39, 283\u2013290 (2013).","journal-title":"Semin Thromb. Hemost."},{"key":"15089_CR8","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/ijlh.13977","volume":"45","author":"J Cabo","year":"2023","unstructured":"Cabo, J. et al. Variability among commercial batches of normal pooled plasma in lupus anticoagulant testing. Int. J. Lab. Hematol. 45, 126\u2013136 (2023).","journal-title":"Int. J. Lab. Hematol."},{"key":"15089_CR9","doi-asserted-by":"publisher","first-page":"100065","DOI":"10.1016\/j.rpth.2023.100065","volume":"7","author":"M Matsuda","year":"2023","unstructured":"Matsuda, M. et al. Performance characteristics of 5 numerical indexes in mixing test interpretation under coexistence of lupus anticoagulant and coagulation factor deficiency. Res. Pract. Thromb. Haemost. 7, 100065 (2023).","journal-title":"Res. Pract. Thromb. Haemost"},{"key":"15089_CR10","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1055\/s-0038-1657690","volume":"78","author":"PJ Braun","year":"1997","unstructured":"Braun, P. J. et al. Properties of optical data from activated partial thromboplastin time and prothrombin time assays. Thromb. Haemost. 78, 1079\u20131087 (1997).","journal-title":"Thromb. Haemost"},{"key":"15089_CR11","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1055\/s-0037-1613023","volume":"87","author":"M Shima","year":"2002","unstructured":"Shima, M. et al. The utility of activated partial thromboplastin time (aPTT) clot waveform analysis in the investigation of hemophilia A patients with very low levels of factor VIII activity (FVIII:C). Thromb. Haemost. 87, 436\u2013441 (2002).","journal-title":"Thromb. Haemost"},{"key":"15089_CR12","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1111\/jth.12287","volume":"11","author":"M Shima","year":"2013","unstructured":"Shima, M., Thachil, J., Nair, S. C. & Srivastava, A. Scientific and standardization committee. Towards standardization of clot waveform analysis and recommendations for its clinical applications. J. Thromb. Haemost. 11, 1417\u20131420 (2013).","journal-title":"J. Thromb. Haemost"},{"key":"15089_CR13","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s12185-016-2108-x","volume":"105","author":"T Matsumoto","year":"2017","unstructured":"Matsumoto, T., Nogami, K. & Shima, M. A combined approach using global coagulation assays quickly differentiates coagulation disorders with prolonged aPTT and low levels of FVIII activity. Int. J. Hematol. 105, 174\u2013183 (2017).","journal-title":"Int. J. Hematol."},{"key":"15089_CR14","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/ijlh.12724","volume":"39","author":"PO Sevenet","year":"2017","unstructured":"Sevenet, P. O. & Depasse, F. Clot waveform analysis: where do we stand in 2017? Int. J. Lab. Hematol. 39, 561\u2013568 (2017).","journal-title":"Int. J. Lab. Hematol."},{"key":"15089_CR15","doi-asserted-by":"publisher","first-page":"107602962091202","DOI":"10.1177\/1076029620912027","volume":"26","author":"H Wada","year":"2020","unstructured":"Wada, H., Matsumoto, T., Ohishi, K., Shiraki, K. & Shimaoka, M. Update on the clot waveform analysis. Clin. Appl. Thromb. Hemost. 26, 1076029620912027 (2020).","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"15089_CR16","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.1751-553X.2010.01248.x","volume":"33","author":"C Solano","year":"2011","unstructured":"Solano, C., Zerafa, P. & Bird, R. A study of atypical APTT derivative curves on the ACL TOP coagulation analyser. Int. J. Lab. Hematol. 33, 67\u201378 (2011).","journal-title":"Int. J. Lab. Hematol."},{"key":"15089_CR17","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1097\/MBC.0000000000000436","volume":"27","author":"N Tokunaga","year":"2016","unstructured":"Tokunaga, N. et al. Usefulness of the second-derivative curve of activated partial thromboplastin time on the ACL-TOP coagulation analyzer for detecting factor deficiencies. Blood Coagul Fibrinolysis. 27, 474\u2013476 (2016).","journal-title":"Blood Coagul Fibrinolysis"},{"key":"15089_CR18","doi-asserted-by":"publisher","first-page":"107602962097881","DOI":"10.1177\/1076029620978810","volume":"26","author":"D Shimomura","year":"2020","unstructured":"Shimomura, D. et al. The first-derivative curve of the coagulation waveform reveals the cause of aPTT prolongation. Clin. Appl. Thromb. Hemost. 26, 1076029620978810 (2020).","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"15089_CR19","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1111\/jth.14022","volume":"16","author":"K Nogami","year":"2018","unstructured":"Nogami, K. et al. Modified clot waveform analysis to measure plasma coagulation potential in the presence of the anti-factor ixa\/factor X bispecific antibody Emicizumab. J. Thromb. Haemost. 16, 1078\u20131088 (2018).","journal-title":"J. Thromb. Haemost"},{"key":"15089_CR20","doi-asserted-by":"publisher","first-page":"119887","DOI":"10.1016\/j.cca.2024.119887","volume":"562","author":"M Wakui","year":"2024","unstructured":"Wakui, M. et al. Comparison of clot waveform analysis with or without adjustment between prothrombin time and activated partial thromboplastin time assays to assess in vitro effects of direct oral anticoagulants. Clin. Chim. Acta. 562, 119887 (2024).","journal-title":"Clin. Chim. Acta"},{"key":"15089_CR21","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1111\/ijlh.12975","volume":"41","author":"J Evrard","year":"2019","unstructured":"Evrard, J. et al. Optimal wavelength for the clot waveform analysis: determination of the best resolution with minimal interference of the reagents. Int. J. Lab. Hematol. 41, 316\u2013324 (2019).","journal-title":"Int. J. Lab. Hematol."},{"key":"15089_CR22","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S1386-5056(97)00065-8","volume":"46","author":"TB Givens","year":"1997","unstructured":"Givens, T. B. & Braun, P. J. Classification of factor deficiencies from coagulation assays using neural networks. Int. J. Med. Inf. 46, 129\u2013143 (1997).","journal-title":"Int. J. Med. Inf."},{"key":"15089_CR23","doi-asserted-by":"publisher","first-page":"e258","DOI":"10.1002\/hsr2.258","volume":"4","author":"K Kanouchi","year":"2021","unstructured":"Kanouchi, K., Narimatsu, H., Shirata, T. & Morikane, K. Diagnostic analysis of lupus anticoagulant using clot waveform analysis in activated partial thromboplastin time prolonged cases: A retrospective analysis. Health Sci. Rep. 4, e258 (2021).","journal-title":"Health Sci. Rep."},{"key":"15089_CR24","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1136\/jclinpath-2018-205517","volume":"72","author":"M Wakui","year":"2019","unstructured":"Wakui, M. et al. Assessment of in vitro effects of direct thrombin inhibitors and activated factor X inhibitors through clot waveform analysis. J. Clin. Pathol. 72, 244\u2013250 (2019).","journal-title":"J. Clin. Pathol."},{"key":"15089_CR25","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1136\/jclinpath-2020-206835","volume":"74","author":"M Wakui","year":"2021","unstructured":"Wakui, M. et al. Characterisation of antithrombin-dependent anticoagulants through clot waveform analysis to potentially distinguish them from antithrombin-independent inhibitors targeting activated coagulation factors. J. Clin. Pathol. 74, 251\u2013256 (2021).","journal-title":"J. Clin. Pathol."},{"key":"15089_CR26","first-page":"537","volume":"46","author":"M Matsuda","year":"2021","unstructured":"Matsuda, M., Morita, Y., Moriyama, M., Hoshiyama, Y. & Narita, I. Establishment of activated partial thromboplastin time reference intervals and their clinical utility, using three reagents. Clin. Lab. Sci. J. 46, 537\u2013549 (2021).","journal-title":"Clin. Lab. Sci. J."},{"key":"15089_CR27","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.3390\/diagnostics13142447","volume":"13","author":"WH Wong","year":"2023","unstructured":"Wong, W. H. et al. Reagent effects on the activated partial thromboplastin time clot waveform analysis: A multi-centre study. Diagnostics (Basel). 13, 2447 (2023).","journal-title":"Diagnostics (Basel)"},{"key":"15089_CR28","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1007\/s12185-020-02983-x","volume":"112","author":"M Ieko","year":"2020","unstructured":"Ieko, M. et al. Expert consensus regarding standardization of sample Preparation for clotting time assays. Int. J. Hematol. 112, 614\u2013620 (2020).","journal-title":"Int. J. Hematol."},{"key":"15089_CR29","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.neucom.2015.09.116","volume":"187","author":"Y Guo","year":"2016","unstructured":"Guo, Y. et al. Deep learning for visual understanding: A review. Neurocomputing 187, 27\u201348 (2016).","journal-title":"Neurocomputing"},{"key":"15089_CR30","doi-asserted-by":"publisher","first-page":"5455","DOI":"10.1007\/s10462-020-09825-6","volume":"53","author":"A Khan","year":"2020","unstructured":"Khan, A., Sohail, A., Zahoora, U. & Qureshi, A. S. A survey of the recent architectures of deep convolutional neural networks. Artif. Intell. Rev. 53, 5455\u20135516 (2020).","journal-title":"Artif. Intell. Rev."},{"key":"15089_CR31","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.3390\/electronics10202470","volume":"10","author":"D Bhatt","year":"2021","unstructured":"Bhatt, D. et al. CNN variants for computer vision: history, architecture, application, challenges and future scope. Electronics 10, 2470 (2021).","journal-title":"Electronics"},{"key":"15089_CR32","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.media.2017.07.005","volume":"42","author":"G Litjens","year":"2017","unstructured":"Litjens, G. et al. A survey on deep learning in medical image analysis. Med. Image Anal. 42, 60\u201388 (2017).","journal-title":"Med. Image Anal."},{"key":"15089_CR33","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-3-030-33128-3_1","volume":"1213","author":"HP Chan","year":"2020","unstructured":"Chan, H. P., Samala, R. K., Hadjiiski, L. M. & Zhou, C. Deep learning in medical image analysis. Adv. Exp. Med. Biol. 1213, 3\u201321 (2020).","journal-title":"Adv. Exp. Med. Biol."},{"key":"15089_CR34","doi-asserted-by":"publisher","first-page":"102444","DOI":"10.1016\/j.media.2022.102444","volume":"79","author":"X Chen","year":"2022","unstructured":"Chen, X. et al. Recent advances and clinical applications of deep learning in medical image analysis. Med. Image Anal. 79, 102444 (2022).","journal-title":"Med. Image Anal."},{"key":"15089_CR35","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.3390\/cancers11091235","volume":"11","author":"K Munir","year":"2019","unstructured":"Munir, K., Elahi, H., Ayub, A., Frezza, F. & Rizzi, A. Cancer diagnosis using deep learning: A bibliographic review. Cancers 11, 1235 (2019).","journal-title":"Cancers"},{"key":"15089_CR36","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s11548-021-02326-z","volume":"16","author":"S Badrigilan","year":"2021","unstructured":"Badrigilan, S. et al. Deep learning approaches for automated classification and segmentation of head and neck cancers and brain tumors in magnetic resonance images: a meta-analysis study. Int. J. Comput. Assist. Radiol. Surg. 16, 529\u2013542 (2021).","journal-title":"Int. J. Comput. Assist. Radiol. Surg."},{"key":"15089_CR37","first-page":"e19580","volume":"13","author":"AS Alhasan","year":"2021","unstructured":"Alhasan, A. S. Clinical applications of artificial intelligence, machine learning, and deep learning in the imaging of gliomas: A systematic review. Cureus 13, e19580 (2021).","journal-title":"Cureus"},{"key":"15089_CR38","unstructured":"Abadi, M. et al. TensorFlow: Large-scale machine learning on heterogeneous distributed systems. Preprint arXiv (2016). https:\/\/arxiv.org\/abs\/1603.04467"},{"key":"15089_CR39","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.cels.2016.01.009","volume":"2","author":"L Rampasek","year":"2016","unstructured":"Rampasek, L., Goldenberg, A. & TensorFlow Biology\u2019s gateway to deep learning? Cell. Syst. 2, 12\u201314 (2016).","journal-title":"Cell. Syst."},{"key":"15089_CR40","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1111\/j.1651-2227.2006.00178.x","volume":"96","author":"AK Akobeng","year":"2007","unstructured":"Akobeng, A. K. Understanding diagnostic tests 3: receiver operating characteristic curves. Acta Paediatr. 96, 644\u2013647 (2007).","journal-title":"Acta Paediatr."},{"key":"15089_CR41","first-page":"2825","volume":"12","author":"F Pedregosa","year":"2011","unstructured":"Pedregosa, F. et al. Scikit-learn: machine learning in python. J. Mach. Learn. Res. 12, 2825\u20132830 (2011).","journal-title":"J. Mach. Learn. Res."},{"key":"15089_CR42","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1111\/ijlh.14289","volume":"46","author":"D Shimomura","year":"2024","unstructured":"Shimomura, D. et al. New method to differentiate between lupus anticoagulants, progressive coagulation inhibitors and coagulation factor deficiencies in the mixing tests. Int. J. Lab. Hematol. 46, 1084\u20131091 (2024).","journal-title":"Int. J. Lab. Hematol."},{"key":"15089_CR43","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/rth2.12069","volume":"2","author":"O Kumano","year":"2017","unstructured":"Kumano, O. & Moore, G. W. Lupus anticoagulant mixing tests for multiple reagents are more sensitive if interpreted with a mixing test-specific cut-off than index of Circulating anticoagulant. Res. Pract. Thromb. Haemost. 2, 105\u2013113 (2017).","journal-title":"Res. Pract. Thromb. Haemost"},{"key":"15089_CR44","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1471-2105-12-77","volume":"12","author":"X Robin","year":"2011","unstructured":"Robin, X. et al. pROC: an open-source package for R and S\u2009+\u2009to analyze and compare ROC curves. BMC Bioinform. 12, 77 (2011).","journal-title":"BMC Bioinform."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15089-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15089-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15089-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T08:24:31Z","timestamp":1757319871000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15089-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,2]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["15089"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-15089-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,2]]},"assertion":[{"value":"10 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"T.S., Y.T., H.K., K.N., and N.A. are employee of Sysmex Corp., Japan. The other authors have no competing interests to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"32336"}}